Global Cell-Free DNA Blood Collection Tubes Market Growth 2026-2032

October 2026 | 174 pages | ID: G46E134A5901EN
LP Information

Abstracts

The global Cell-Free DNA Blood Collection Tubes market size is predicted to grow from US$ 111 million in 2025 to US$ 180 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

Cell-Free DNA Blood Collection Tubes are specialized evacuated blood collection consumables designed for direct collection, stabilization, storage, and transportation of human whole blood prior to cell-free DNA analysis. These products combine anticoagulation with dedicated cell-stabilizing and nucleic-acid-preserving formulations to reduce leukocyte lysis, genomic DNA release, nuclease-driven degradation, and other pre-analytical changes that can alter plasma cfDNA profiles. Commercial products are typically supplied as approximately 5–10 mL blood collection tubes in glass or polymer formats, with 10 mL-class tubes representing a widely adopted configuration. Depending on product formulation and regulatory status, stabilized whole blood can generally be transported and stored for several days at ambient or controlled temperatures before plasma separation. The market primarily covers dedicated cfDNA preservation tubes and multi-analyte cell-free nucleic acid preservation tubes used in non-invasive prenatal testing, oncology liquid biopsy, molecular residual disease monitoring, therapy selection, companion diagnostics, transplant rejection monitoring, and related molecular testing workflows. The product is positioned at the pre-analytical stage of the molecular diagnostics and liquid biopsy industry chain, where sample integrity directly affects downstream extraction, PCR, digital PCR, and next-generation sequencing performance.

Key Findings

Global sales volume was approximately 25.5 million tubes in 2025 and is estimated at about 27.3 million tubes in 2026

The weighted global manufacturer-level ASP was approximately US$4.42 per tube in 2025

NIPT accounted for approximately 52% of 2025 unit demand and remained the largest application

Oncology liquid biopsy and MRD represented approximately 27% of unit demand and are gaining structural importance

China has the largest concentration of identified core manufacturing companies in the study database

Market Trends

The Cell-Free DNA Blood Collection Tubes market is shifting from basic blood collection toward increasingly standardized pre-analytical sample management. Product development is focused on extending whole-blood stability, reducing genomic DNA contamination caused by nucleated-cell lysis, improving tolerance to transportation temperature variation, and supporting decentralized sample collection followed by centralized molecular testing. Established products such as 10 mL-class dedicated cfDNA tubes remain central to clinical workflows, while multi-analyte preservation products capable of stabilizing cfDNA together with other circulating nucleic acids are broadening the technical scope of liquid biopsy sample collection. Another structural change is the transition from research-oriented products toward regulated IVD configurations validated with specific downstream diagnostic workflows. This is increasing the importance of compatibility studies, stability validation, automated plasma-processing workflows, and integration with PCR and next-generation sequencing platforms. The market is therefore evolving from a relatively simple specialty consumable category into a regulated pre-analytical component of complete molecular diagnostic workflows.

Market Dynamics

Drivers

Growth is primarily supported by rising adoption of non-invasive prenatal testing, oncology liquid biopsy, molecular residual disease testing, precision therapy selection, and donor-derived cfDNA monitoring after organ transplantation. These applications require relatively consistent plasma cfDNA quality even when blood cannot be processed immediately after collection. Specialized stabilization tubes therefore address a fundamental pre-analytical problem by reducing leukocyte lysis and genomic DNA contamination during transportation and temporary storage. Expansion of centralized molecular laboratories also increases the need to transport samples over longer distances from hospitals and collection sites to testing centers. In oncology, rapidly increasing clinical MRD testing further supports demand for standardized blood collection: Natera processed approximately 800,800 oncology tests in 2025, including about 769,700 clinical MRD tests, while CareDx reported approximately 200,000 testing-service tests in transplantation-related diagnostics during the same year.

Restraints

The principal restraint is the substantial price premium over conventional EDTA blood collection tubes. Stabilizer formulation, specialized filling processes, quality control, shelf-life validation, sterilization, regulatory registration, and clinical workflow validation all add manufacturing and commercialization costs. At the same time, major testing laboratories purchase tubes in large volumes and can exert downward pressure on manufacturer-level pricing, while lower-cost Asian suppliers are increasing price competition. The category also faces substitution in workflows where blood can be processed rapidly after collection, because standard EDTA tubes can remain economically attractive when plasma separation occurs within a tightly controlled time window. As a result, the economic advantage of specialized cfDNA preservation tubes is strongest in distributed collection, sample shipping, centralized testing, and workflows requiring longer pre-analytical stability.

Opportunities

The most attractive incremental opportunities are emerging from oncology applications where repeated blood collection is becoming embedded in longitudinal patient management rather than being limited to a single diagnostic event. Molecular residual disease, recurrence surveillance, treatment-response monitoring, and companion diagnostic workflows can create multiple blood draws per patient and therefore generate higher recurring tube consumption than many one-time screening applications. Transplant medicine also provides a recurring-use model because donor-derived cfDNA testing may be performed repeatedly after transplantation. Additional opportunities are developing in emerging markets where NIPT and oncology sequencing capacity are expanding but centralized testing infrastructure still requires reliable transportation of whole-blood samples. Manufacturers able to combine competitive pricing with validated multi-day stability, regulatory compliance, automated production, and compatibility with major downstream extraction and sequencing workflows are positioned to capture a larger share of this incremental demand.

Challenges

The industry continues to face technical and commercial standardization challenges. Stability claims are not directly comparable across products because storage temperature, duration, sample handling conditions, analytical methods, and regulatory versions vary by manufacturer. For example, PAXgene Blood ccfDNA Tube documentation supports stabilization for up to 10 days at temperatures up to 25°C, while other products use different temperature-duration combinations. Clinical laboratories therefore evaluate products based not only on nominal preservation time but also on hemolysis, genomic DNA contamination, cfDNA yield, fragment-size distribution, downstream assay performance, and workflow compatibility. Another challenge is the relatively concentrated purchasing structure of large NIPT and oncology laboratories, which can make supplier qualification highly valuable but also increase customer concentration risk. New entrants must consequently overcome both manufacturing barriers and lengthy validation cycles before achieving meaningful clinical-volume adoption.

Industry Chain Analysis

The upstream portion of the Cell-Free DNA Blood Collection Tubes industry includes medical-grade glass and polymer tube materials, elastomer closures, safety caps, labels, anticoagulants such as EDTA, proprietary cell-stabilization formulations, packaging materials, molding equipment, vacuum-forming and filling equipment, sterilization services, and quality-control materials. The technical differentiation of the product is concentrated less in the basic tube body than in stabilizer chemistry, controlled reagent filling, vacuum consistency, tube-closure performance, sterilization, shelf-life control, and the ability to maintain plasma cfDNA integrity under transportation conditions. These factors distinguish specialized cfDNA tubes from conventional evacuated blood collection tubes.

The midstream consists of formulation development, tube molding or forming, stabilizer filling, vacuum preparation, closure assembly, labeling, sterilization, stability testing, regulatory registration, and commercial supply. Large blood collection manufacturers benefit from automated production scale and established quality systems, while specialist molecular-diagnostics suppliers compete through proprietary preservation chemistry and assay-specific validation. Downstream demand is generated by NIPT laboratories, oncology liquid biopsy providers, transplant diagnostics, hospital molecular laboratories, independent reference laboratories, pharmaceutical clinical trials, and research programs. Value creation progressively shifts from relatively standardized tube-body manufacturing toward preservation chemistry, validated pre-analytical performance, regulatory status, and integration into high-value diagnostic workflows. This explains why the selling price of specialized cfDNA tubes remains substantially above that of conventional blood collection tubes despite relatively low material content.

Segment Insights

Dedicated cfDNA Preservation Tubes constitute the mainstream product structure because most established clinical workflows require a clearly validated solution for preserving plasma cfDNA while minimizing the release of intracellular genomic DNA. Multi-Analyte Cell-Free Nucleic Acid Preservation Tubes form a smaller but strategically relevant segment, particularly in research and emerging liquid biopsy workflows seeking to recover cfDNA together with cfRNA or other circulating molecular targets from the same specimen. In terms of specifications, 10 mL-class tubes remain an important commercial format, although smaller and intermediate-volume products are also available. Plastic tubes are increasingly common due to transportation safety and manufacturing scalability, while glass tubes continue to be supplied by several manufacturers.

By application, NIPT accounted for approximately 52% of global unit demand in 2025 and remained the largest consumption segment. Oncology liquid biopsy, including cancer detection, therapy selection, companion diagnostics, and MRD monitoring, represented approximately 27% and has become the most important source of structural demand diversification. Transplant-related cfDNA monitoring accounted for a smaller share, while pharmaceutical research, clinical trials, infectious disease applications, and other molecular testing workflows formed the remaining demand base. The application mix is expected to gradually shift toward oncology and other repeated-testing scenarios as cfDNA testing moves beyond prenatal screening into longitudinal disease management.

Downstream Market Opportunities

The largest established downstream opportunity remains NIPT, where high testing volumes and centralized sequencing workflows create stable recurring demand for standardized blood collection. The strongest incremental opportunity, however, is developing in oncology. MRD surveillance, recurrence monitoring, treatment-response assessment, molecular profiling, and companion diagnostics can require repeated sampling during the patient journey, creating higher lifetime tube consumption per patient. Transplant monitoring provides a similar recurring-demand mechanism, while pharmaceutical clinical trials create additional requirements for harmonized sample collection across geographically dispersed study sites. The commercial opportunity is therefore shifting from dependence on a single high-volume prenatal application toward a broader portfolio of clinical workflows in which repeat testing and long-distance specimen logistics increase the value of reliable cfDNA stabilization.

Regional Insights

North America is a major clinical demand center for Cell-Free DNA Blood Collection Tubes, supported by large-scale oncology liquid biopsy, MRD, transplant diagnostics, and established NIPT testing infrastructure. The region also contains important specialist technology developers and major clinical testing companies, which accelerates validation of specialized blood collection tubes within regulated workflows. Europe has a mature pre-analytical and blood collection industry and a strong base of internationally active manufacturers, particularly in Germany, Austria, Switzerland, and the United Kingdom. Regulatory transition toward more rigorous IVD requirements reinforces the importance of validated products and established quality systems.

Asia has a different market structure. China has the highest concentration of core manufacturing companies identified in this study and combines very large conventional blood collection manufacturing capacity with a growing group of specialized cfDNA tube manufacturers. This supports localization and downward pressure on manufacturing costs. Japan maintains a technologically advanced blood collection and diagnostics base, including domestic manufacturing of dedicated cfDNA collection products, while South Korea has developed several specialist manufacturers with proprietary vacuum blood collection systems. India is represented by a smaller group of regional manufacturers, whereas Southeast Asia and Taiwan remain more dependent on international and imported product platforms. Asia is therefore becoming increasingly important not only as a testing market but also as a production and supply base.

Competitive Landscape Analysis

The competitive landscape combines global blood collection manufacturers, specialist cfDNA preservation technology companies, and a growing group of Asian manufacturers. At the upper end of the market, Becton, Dickinson and Company, Greiner Bio-One, Streck, SARSTEDT, and SEKISUI MEDICAL possess advantages in manufacturing quality systems, international distribution, regulatory experience, and large-scale production. Streck occupies a particularly important position in specialized cfDNA preservation, with more than 35 million Cell-Free DNA BCT tubes sold globally by the time of its U.S. FDA De Novo clearance, demonstrating substantial historical adoption in molecular testing workflows. Roche-branded Cell-Free DNA Collection Tubes have also exceeded one million units of worldwide usage, illustrating the commercial importance of diagnostic-company validation and distribution even where manufacturing and brand ownership are separated. Chinese manufacturers such as Liuyang Sanli Medical Technology Development, Hebei Xinle Sci&Tech, Improve Medical Instruments, Jiangsu CoWin Biotech, Hefei Lakebio Medical Technologies, and other validated producers compete through manufacturing scale, localized supply, and lower cost structures, while Korean manufacturers including SOYAGREENTEC, LABEX, and AccuGene expand the regional specialist supply base. Competitive advantage increasingly depends on the combination of preservation chemistry, automated manufacturing, stability performance, regulatory approvals, downstream assay validation, global distribution, and the ability to supply high-volume testing organizations consistently rather than on tube-body manufacturing alone.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Cell-Free DNA Blood Collection Tubes Industry Forecast” looks at past sales and reviews total world Cell-Free DNA Blood Collection Tubes sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell-Free DNA Blood Collection Tubes sales for 2026 through 2032. With Cell-Free DNA Blood Collection Tubes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell-Free DNA Blood Collection Tubes industry.

This Insight Report provides a comprehensive analysis of the global Cell-Free DNA Blood Collection Tubes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell-Free DNA Blood Collection Tubes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell-Free DNA Blood Collection Tubes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell-Free DNA Blood Collection Tubes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell-Free DNA Blood Collection Tubes.

This report presents a comprehensive overview, market shares, and growth opportunities of Cell-Free DNA Blood Collection Tubes market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

• Dedicated cfDNA Preservation Tubes
• Multi-Analyte Cell-Free Nucleic Acid Preservation Tubes
• Other

Segmentation by Blood Draw Volume:

• Up to 5 mL
• More than 5 mL and Less than 10 mL
• 10 mL and Above
• Other

Segmentation by Application:

• Non-Invasive Prenatal Testing
• Cancer Screening and Early Detection
• Therapy Selection and Companion Diagnostics
• Molecular Residual Disease Monitoring
• Transplant Rejection Monitoring
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Becton, Dickinson and Company
• Greiner Bio-One GmbH
• Streck, LLC
• SARSTEDT AG & Co. KG
• SEKISUI MEDICAL CO., LTD.
• Liuyang Sanli Medical Technology Development Co., Ltd.
• Hebei Xinle Sci&Tech Co., Ltd.
• Improve Medical Instruments Co., Ltd.
• Norgen Biotek Corp.
• Nonacus Limited
• SOYAGREENTEC CO., LTD.
• LABEX INC.
• AccuGene, Inc.
• Jiangsu CoWin Biotech Co., Ltd.
• Hefei Lakebio Medical Technologies Co., Ltd.
• Shandong Ande Healthcare Apparatus Co., Ltd.
• BGI Biotechnology Wuhan Co., Ltd.
• Changsha Renji Medical Equipment Co., Ltd.
• Zhejiang SKG Medical Technology Co., Ltd.
• Huachenyang Shenzhen Technology Co., Ltd.
• Dewei Medical Equipment Co., Ltd.
• Guangdong Ardent Biomed Co., Ltd.
• Nasmed Diagnostics Pvt. Ltd.
• Aixgen Technology Heze Co., Ltd.
• YALI Biotech Co., Ltd.
• Xiamen Zhixuan Biotechnology Co., Ltd.
• BioDetect Xiamen Biotechnology Co., Ltd.

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Cell-Free DNA Blood Collection Tubes market?
• What factors are driving Cell-Free DNA Blood Collection Tubes market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Cell-Free DNA Blood Collection Tubes market opportunities vary by end market size?
• How does Cell-Free DNA Blood Collection Tubes break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cell-Free DNA Blood Collection Tubes Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Cell-Free DNA Blood Collection Tubes by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Cell-Free DNA Blood Collection Tubes by Country/Region, 2021, 2025 & 2032
2.2 Cell-Free DNA Blood Collection Tubes Segment by Type
  2.2.1 Dedicated cfDNA Preservation Tubes
  2.2.2 Multi-Analyte Cell-Free Nucleic Acid Preservation Tubes
  2.2.3 Other
  2.2.4 Cell-Free DNA Blood Collection Tubes Sales by Type
    2.2.4.1 Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Type (2021-2026)
    2.2.4.2 Global Cell-Free DNA Blood Collection Tubes Revenue and Market Share by Type (2021-2026)
    2.2.4.3 Global Cell-Free DNA Blood Collection Tubes Sale Price by Type (2021-2026)
2.3 Cell-Free DNA Blood Collection Tubes Segment by Blood Draw Volume
  2.3.1 Up to 5 mL
  2.3.2 More than 5 mL and Less than 10 mL
  2.3.3 10 mL and Above
  2.3.4 Other
  2.3.5 Cell-Free DNA Blood Collection Tubes Sales by Blood Draw Volume
    2.3.5.1 Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Blood Draw Volume (2021-2026)
    2.3.5.2 Global Cell-Free DNA Blood Collection Tubes Revenue and Market Share by Blood Draw Volume (2021-2026)
    2.3.5.3 Global Cell-Free DNA Blood Collection Tubes Sale Price by Blood Draw Volume (2021-2026)
2.4 Cell-Free DNA Blood Collection Tubes Segment by Application
  2.4.1 Non-Invasive Prenatal Testing
  2.4.2 Cancer Screening and Early Detection
  2.4.3 Therapy Selection and Companion Diagnostics
  2.4.4 Molecular Residual Disease Monitoring
  2.4.5 Transplant Rejection Monitoring
  2.4.6 Other
  2.4.7 Cell-Free DNA Blood Collection Tubes Sales by Application
    2.4.7.1 Global Cell-Free DNA Blood Collection Tubes Sale Market Share by Application (2021-2026)
    2.4.7.2 Global Cell-Free DNA Blood Collection Tubes Revenue and Market Share by Application (2021-2026)
    2.4.7.3 Global Cell-Free DNA Blood Collection Tubes Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Cell-Free DNA Blood Collection Tubes Breakdown Data by Company
  3.1.1 Global Cell-Free DNA Blood Collection Tubes Annual Sales by Company (2021-2026)
  3.1.2 Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Company (2021-2026)
3.2 Global Cell-Free DNA Blood Collection Tubes Annual Revenue by Company (2021-2026)
  3.2.1 Global Cell-Free DNA Blood Collection Tubes Revenue by Company (2021-2026)
  3.2.2 Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Company (2021-2026)
3.3 Global Cell-Free DNA Blood Collection Tubes Sale Price by Company
3.4 Key Manufacturers Cell-Free DNA Blood Collection Tubes Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Cell-Free DNA Blood Collection Tubes Product Location Distribution
  3.4.2 Players Cell-Free DNA Blood Collection Tubes Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR CELL-FREE DNA BLOOD COLLECTION TUBES BY GEOGRAPHIC REGION

4.1 World Historic Cell-Free DNA Blood Collection Tubes Market Size by Geographic Region (2021-2026)
  4.1.1 Global Cell-Free DNA Blood Collection Tubes Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Cell-Free DNA Blood Collection Tubes Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Cell-Free DNA Blood Collection Tubes Market Size by Country/Region (2021-2026)
  4.2.1 Global Cell-Free DNA Blood Collection Tubes Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Cell-Free DNA Blood Collection Tubes Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell-Free DNA Blood Collection Tubes Sales Growth
4.4 APAC Cell-Free DNA Blood Collection Tubes Sales Growth
4.5 Europe Cell-Free DNA Blood Collection Tubes Sales Growth
4.6 Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales Growth

5 AMERICAS

5.1 Americas Cell-Free DNA Blood Collection Tubes Sales by Country
  5.1.1 Americas Cell-Free DNA Blood Collection Tubes Sales by Country (2021-2026)
  5.1.2 Americas Cell-Free DNA Blood Collection Tubes Revenue by Country (2021-2026)
5.2 Americas Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026)
5.3 Americas Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cell-Free DNA Blood Collection Tubes Sales by Region
  6.1.1 APAC Cell-Free DNA Blood Collection Tubes Sales by Region (2021-2026)
  6.1.2 APAC Cell-Free DNA Blood Collection Tubes Revenue by Region (2021-2026)
6.2 APAC Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026)
6.3 APAC Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Cell-Free DNA Blood Collection Tubes by Country
  7.1.1 Europe Cell-Free DNA Blood Collection Tubes Sales by Country (2021-2026)
  7.1.2 Europe Cell-Free DNA Blood Collection Tubes Revenue by Country (2021-2026)
7.2 Europe Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026)
7.3 Europe Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cell-Free DNA Blood Collection Tubes by Country
  8.1.1 Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Cell-Free DNA Blood Collection Tubes Revenue by Country (2021-2026)
8.2 Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026)
8.3 Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cell-Free DNA Blood Collection Tubes
10.3 Manufacturing Process Analysis of Cell-Free DNA Blood Collection Tubes
10.4 Industry Chain Structure of Cell-Free DNA Blood Collection Tubes

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Cell-Free DNA Blood Collection Tubes Distributors
11.3 Cell-Free DNA Blood Collection Tubes Customer

12 WORLD FORECAST REVIEW FOR CELL-FREE DNA BLOOD COLLECTION TUBES BY GEOGRAPHIC REGION

12.1 Global Cell-Free DNA Blood Collection Tubes Market Size Forecast by Region
  12.1.1 Global Cell-Free DNA Blood Collection Tubes Forecast by Region (2027-2032)
  12.1.2 Global Cell-Free DNA Blood Collection Tubes Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Cell-Free DNA Blood Collection Tubes Forecast by Type (2027-2032)
12.7 Global Cell-Free DNA Blood Collection Tubes Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Becton, Dickinson and Company
  13.1.1 Becton, Dickinson and Company Company Information
  13.1.2 Becton, Dickinson and Company Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.1.3 Becton, Dickinson and Company Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Becton, Dickinson and Company Main Business Overview
  13.1.5 Becton, Dickinson and Company Latest Developments
13.2 Greiner Bio-One GmbH
  13.2.1 Greiner Bio-One GmbH Company Information
  13.2.2 Greiner Bio-One GmbH Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.2.3 Greiner Bio-One GmbH Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Greiner Bio-One GmbH Main Business Overview
  13.2.5 Greiner Bio-One GmbH Latest Developments
13.3 Streck, LLC
  13.3.1 Streck, LLC Company Information
  13.3.2 Streck, LLC Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.3.3 Streck, LLC Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Streck, LLC Main Business Overview
  13.3.5 Streck, LLC Latest Developments
13.4 SARSTEDT AG & Co. KG
  13.4.1 SARSTEDT AG & Co. KG Company Information
  13.4.2 SARSTEDT AG & Co. KG Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.4.3 SARSTEDT AG & Co. KG Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 SARSTEDT AG & Co. KG Main Business Overview
  13.4.5 SARSTEDT AG & Co. KG Latest Developments
13.5 SEKISUI MEDICAL CO., LTD.
  13.5.1 SEKISUI MEDICAL CO., LTD. Company Information
  13.5.2 SEKISUI MEDICAL CO., LTD. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.5.3 SEKISUI MEDICAL CO., LTD. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 SEKISUI MEDICAL CO., LTD. Main Business Overview
  13.5.5 SEKISUI MEDICAL CO., LTD. Latest Developments
13.6 Liuyang Sanli Medical Technology Development Co., Ltd.
  13.6.1 Liuyang Sanli Medical Technology Development Co., Ltd. Company Information
  13.6.2 Liuyang Sanli Medical Technology Development Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.6.3 Liuyang Sanli Medical Technology Development Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Liuyang Sanli Medical Technology Development Co., Ltd. Main Business Overview
  13.6.5 Liuyang Sanli Medical Technology Development Co., Ltd. Latest Developments
13.7 Hebei Xinle Sci&Tech Co., Ltd.
  13.7.1 Hebei Xinle Sci&Tech Co., Ltd. Company Information
  13.7.2 Hebei Xinle Sci&Tech Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.7.3 Hebei Xinle Sci&Tech Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Hebei Xinle Sci&Tech Co., Ltd. Main Business Overview
  13.7.5 Hebei Xinle Sci&Tech Co., Ltd. Latest Developments
13.8 Improve Medical Instruments Co., Ltd.
  13.8.1 Improve Medical Instruments Co., Ltd. Company Information
  13.8.2 Improve Medical Instruments Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.8.3 Improve Medical Instruments Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Improve Medical Instruments Co., Ltd. Main Business Overview
  13.8.5 Improve Medical Instruments Co., Ltd. Latest Developments
13.9 Norgen Biotek Corp.
  13.9.1 Norgen Biotek Corp. Company Information
  13.9.2 Norgen Biotek Corp. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.9.3 Norgen Biotek Corp. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Norgen Biotek Corp. Main Business Overview
  13.9.5 Norgen Biotek Corp. Latest Developments
13.10 Nonacus Limited
  13.10.1 Nonacus Limited Company Information
  13.10.2 Nonacus Limited Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.10.3 Nonacus Limited Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Nonacus Limited Main Business Overview
  13.10.5 Nonacus Limited Latest Developments
13.11 SOYAGREENTEC CO., LTD.
  13.11.1 SOYAGREENTEC CO., LTD. Company Information
  13.11.2 SOYAGREENTEC CO., LTD. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.11.3 SOYAGREENTEC CO., LTD. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 SOYAGREENTEC CO., LTD. Main Business Overview
  13.11.5 SOYAGREENTEC CO., LTD. Latest Developments
13.12 LABEX INC.
  13.12.1 LABEX INC. Company Information
  13.12.2 LABEX INC. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.12.3 LABEX INC. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 LABEX INC. Main Business Overview
  13.12.5 LABEX INC. Latest Developments
13.13 AccuGene, Inc.
  13.13.1 AccuGene, Inc. Company Information
  13.13.2 AccuGene, Inc. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.13.3 AccuGene, Inc. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 AccuGene, Inc. Main Business Overview
  13.13.5 AccuGene, Inc. Latest Developments
13.14 Jiangsu CoWin Biotech Co., Ltd.
  13.14.1 Jiangsu CoWin Biotech Co., Ltd. Company Information
  13.14.2 Jiangsu CoWin Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.14.3 Jiangsu CoWin Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.14.4 Jiangsu CoWin Biotech Co., Ltd. Main Business Overview
  13.14.5 Jiangsu CoWin Biotech Co., Ltd. Latest Developments
13.15 Hefei Lakebio Medical Technologies Co., Ltd.
  13.15.1 Hefei Lakebio Medical Technologies Co., Ltd. Company Information
  13.15.2 Hefei Lakebio Medical Technologies Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.15.3 Hefei Lakebio Medical Technologies Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.15.4 Hefei Lakebio Medical Technologies Co., Ltd. Main Business Overview
  13.15.5 Hefei Lakebio Medical Technologies Co., Ltd. Latest Developments
13.16 Shandong Ande Healthcare Apparatus Co., Ltd.
  13.16.1 Shandong Ande Healthcare Apparatus Co., Ltd. Company Information
  13.16.2 Shandong Ande Healthcare Apparatus Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.16.3 Shandong Ande Healthcare Apparatus Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.16.4 Shandong Ande Healthcare Apparatus Co., Ltd. Main Business Overview
  13.16.5 Shandong Ande Healthcare Apparatus Co., Ltd. Latest Developments
13.17 BGI Biotechnology Wuhan Co., Ltd.
  13.17.1 BGI Biotechnology Wuhan Co., Ltd. Company Information
  13.17.2 BGI Biotechnology Wuhan Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.17.3 BGI Biotechnology Wuhan Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.17.4 BGI Biotechnology Wuhan Co., Ltd. Main Business Overview
  13.17.5 BGI Biotechnology Wuhan Co., Ltd. Latest Developments
13.18 Changsha Renji Medical Equipment Co., Ltd.
  13.18.1 Changsha Renji Medical Equipment Co., Ltd. Company Information
  13.18.2 Changsha Renji Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.18.3 Changsha Renji Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.18.4 Changsha Renji Medical Equipment Co., Ltd. Main Business Overview
  13.18.5 Changsha Renji Medical Equipment Co., Ltd. Latest Developments
13.19 Zhejiang SKG Medical Technology Co., Ltd.
  13.19.1 Zhejiang SKG Medical Technology Co., Ltd. Company Information
  13.19.2 Zhejiang SKG Medical Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.19.3 Zhejiang SKG Medical Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.19.4 Zhejiang SKG Medical Technology Co., Ltd. Main Business Overview
  13.19.5 Zhejiang SKG Medical Technology Co., Ltd. Latest Developments
13.20 Huachenyang Shenzhen Technology Co., Ltd.
  13.20.1 Huachenyang Shenzhen Technology Co., Ltd. Company Information
  13.20.2 Huachenyang Shenzhen Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.20.3 Huachenyang Shenzhen Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.20.4 Huachenyang Shenzhen Technology Co., Ltd. Main Business Overview
  13.20.5 Huachenyang Shenzhen Technology Co., Ltd. Latest Developments
13.21 Dewei Medical Equipment Co., Ltd.
  13.21.1 Dewei Medical Equipment Co., Ltd. Company Information
  13.21.2 Dewei Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.21.3 Dewei Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.21.4 Dewei Medical Equipment Co., Ltd. Main Business Overview
  13.21.5 Dewei Medical Equipment Co., Ltd. Latest Developments
13.22 Guangdong Ardent Biomed Co., Ltd.
  13.22.1 Guangdong Ardent Biomed Co., Ltd. Company Information
  13.22.2 Guangdong Ardent Biomed Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.22.3 Guangdong Ardent Biomed Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.22.4 Guangdong Ardent Biomed Co., Ltd. Main Business Overview
  13.22.5 Guangdong Ardent Biomed Co., Ltd. Latest Developments
13.23 Nasmed Diagnostics Pvt. Ltd.
  13.23.1 Nasmed Diagnostics Pvt. Ltd. Company Information
  13.23.2 Nasmed Diagnostics Pvt. Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.23.3 Nasmed Diagnostics Pvt. Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.23.4 Nasmed Diagnostics Pvt. Ltd. Main Business Overview
  13.23.5 Nasmed Diagnostics Pvt. Ltd. Latest Developments
13.24 Aixgen Technology Heze Co., Ltd.
  13.24.1 Aixgen Technology Heze Co., Ltd. Company Information
  13.24.2 Aixgen Technology Heze Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.24.3 Aixgen Technology Heze Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.24.4 Aixgen Technology Heze Co., Ltd. Main Business Overview
  13.24.5 Aixgen Technology Heze Co., Ltd. Latest Developments
13.25 YALI Biotech Co., Ltd.
  13.25.1 YALI Biotech Co., Ltd. Company Information
  13.25.2 YALI Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.25.3 YALI Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.25.4 YALI Biotech Co., Ltd. Main Business Overview
  13.25.5 YALI Biotech Co., Ltd. Latest Developments
13.26 Xiamen Zhixuan Biotechnology Co., Ltd.
  13.26.1 Xiamen Zhixuan Biotechnology Co., Ltd. Company Information
  13.26.2 Xiamen Zhixuan Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.26.3 Xiamen Zhixuan Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.26.4 Xiamen Zhixuan Biotechnology Co., Ltd. Main Business Overview
  13.26.5 Xiamen Zhixuan Biotechnology Co., Ltd. Latest Developments
13.27 BioDetect Xiamen Biotechnology Co., Ltd.
  13.27.1 BioDetect Xiamen Biotechnology Co., Ltd. Company Information
  13.27.2 BioDetect Xiamen Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
  13.27.3 BioDetect Xiamen Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales, Revenue, Price and Gross Margin (2021-2026)
  13.27.4 BioDetect Xiamen Biotechnology Co., Ltd. Main Business Overview
  13.27.5 BioDetect Xiamen Biotechnology Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Cell-Free DNA Blood Collection Tubes Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Cell-Free DNA Blood Collection Tubes Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Dedicated cfDNA Preservation Tubes
Table 4. Major Players of Multi-Analyte Cell-Free Nucleic Acid Preservation Tubes
Table 5. Major Players of Other
Table 6. Global Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026) & (Tubes)
Table 7. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Type (2021-2026)
Table 8. Global Cell-Free DNA Blood Collection Tubes Revenue by Type (2021-2026) & ($ million)
Table 9. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Type (2021-2026)
Table 10. Global Cell-Free DNA Blood Collection Tubes Sale Price by Type (2021-2026) & (US$/Tube)
Table 11. Major Players of Up to 5 mL
Table 12. Major Players of More than 5 mL and Less than 10 mL
Table 13. Major Players of 10 mL and Above
Table 14. Major Players of Other
Table 15. Global Cell-Free DNA Blood Collection Tubes Sales by Blood Draw Volume (2021-2026) & (Tubes)
Table 16. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Blood Draw Volume (2021-2026)
Table 17. Global Cell-Free DNA Blood Collection Tubes Revenue by Blood Draw Volume (2021-2026) & ($ million)
Table 18. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Blood Draw Volume (2021-2026)
Table 19. Global Cell-Free DNA Blood Collection Tubes Sale Price by Blood Draw Volume (2021-2026) & (US$/Tube)
Table 20. Global Cell-Free DNA Blood Collection Tubes Sale by Application (2021-2026) & (Tubes)
Table 21. Global Cell-Free DNA Blood Collection Tubes Sale Market Share by Application (2021-2026)
Table 22. Global Cell-Free DNA Blood Collection Tubes Revenue by Application (2021-2026) & ($ million)
Table 23. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Application (2021-2026)
Table 24. Global Cell-Free DNA Blood Collection Tubes Sale Price by Application (2021-2026) & (US$/Tube)
Table 25. Global Cell-Free DNA Blood Collection Tubes Sales by Company (2021-2026) & (Tubes)
Table 26. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Company (2021-2026)
Table 27. Global Cell-Free DNA Blood Collection Tubes Revenue by Company (2021-2026) & ($ millions)
Table 28. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Company (2021-2026)
Table 29. Global Cell-Free DNA Blood Collection Tubes Sale Price by Company (2021-2026) & (US$/Tube)
Table 30. Key Manufacturers Cell-Free DNA Blood Collection Tubes Producing Area Distribution and Sales Area
Table 31. Players Cell-Free DNA Blood Collection Tubes Products Offered
Table 32. Cell-Free DNA Blood Collection Tubes Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 33. New Products and Potential Entrants
Table 34. Market M&A Activity & Strategy
Table 35. Global Cell-Free DNA Blood Collection Tubes Sales by Geographic Region (2021-2026) & (Tubes)
Table 36. Global Cell-Free DNA Blood Collection Tubes Sales Market Share Geographic Region (2021-2026)
Table 37. Global Cell-Free DNA Blood Collection Tubes Revenue by Geographic Region (2021-2026) & ($ millions)
Table 38. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Geographic Region (2021-2026)
Table 39. Global Cell-Free DNA Blood Collection Tubes Sales by Country/Region (2021-2026) & (Tubes)
Table 40. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Country/Region (2021-2026)
Table 41. Global Cell-Free DNA Blood Collection Tubes Revenue by Country/Region (2021-2026) & ($ millions)
Table 42. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Country/Region (2021-2026)
Table 43. Americas Cell-Free DNA Blood Collection Tubes Sales by Country (2021-2026) & (Tubes)
Table 44. Americas Cell-Free DNA Blood Collection Tubes Sales Market Share by Country (2021-2026)
Table 45. Americas Cell-Free DNA Blood Collection Tubes Revenue by Country (2021-2026) & ($ millions)
Table 46. Americas Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026) & (Tubes)
Table 47. Americas Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026) & (Tubes)
Table 48. APAC Cell-Free DNA Blood Collection Tubes Sales by Region (2021-2026) & (Tubes)
Table 49. APAC Cell-Free DNA Blood Collection Tubes Sales Market Share by Region (2021-2026)
Table 50. APAC Cell-Free DNA Blood Collection Tubes Revenue by Region (2021-2026) & ($ millions)
Table 51. APAC Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026) & (Tubes)
Table 52. APAC Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026) & (Tubes)
Table 53. Europe Cell-Free DNA Blood Collection Tubes Sales by Country (2021-2026) & (Tubes)
Table 54. Europe Cell-Free DNA Blood Collection Tubes Revenue by Country (2021-2026) & ($ millions)
Table 55. Europe Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026) & (Tubes)
Table 56. Europe Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026) & (Tubes)
Table 57. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales by Country (2021-2026) & (Tubes)
Table 58. Middle East & Africa Cell-Free DNA Blood Collection Tubes Revenue Market Share by Country (2021-2026)
Table 59. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales by Type (2021-2026) & (Tubes)
Table 60. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales by Application (2021-2026) & (Tubes)
Table 61. Key Market Drivers & Growth Opportunities of Cell-Free DNA Blood Collection Tubes
Table 62. Key Market Challenges & Risks of Cell-Free DNA Blood Collection Tubes
Table 63. Key Industry Trends of Cell-Free DNA Blood Collection Tubes
Table 64. Cell-Free DNA Blood Collection Tubes Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Cell-Free DNA Blood Collection Tubes Distributors List
Table 67. Cell-Free DNA Blood Collection Tubes Customer List
Table 68. Global Cell-Free DNA Blood Collection Tubes Sales Forecast by Region (2027-2032) & (Tubes)
Table 69. Global Cell-Free DNA Blood Collection Tubes Revenue Forecast by Region (2027-2032) & ($ millions)
Table 70. Americas Cell-Free DNA Blood Collection Tubes Sales Forecast by Country (2027-2032) & (Tubes)
Table 71. Americas Cell-Free DNA Blood Collection Tubes Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 72. APAC Cell-Free DNA Blood Collection Tubes Sales Forecast by Region (2027-2032) & (Tubes)
Table 73. APAC Cell-Free DNA Blood Collection Tubes Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Europe Cell-Free DNA Blood Collection Tubes Sales Forecast by Country (2027-2032) & (Tubes)
Table 75. Europe Cell-Free DNA Blood Collection Tubes Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales Forecast by Country (2027-2032) & (Tubes)
Table 77. Middle East & Africa Cell-Free DNA Blood Collection Tubes Revenue Forecast by Country (2027-2032) & ($ millions)
Table 78. Global Cell-Free DNA Blood Collection Tubes Sales Forecast by Type (2027-2032) & (Tubes)
Table 79. Global Cell-Free DNA Blood Collection Tubes Revenue Forecast by Type (2027-2032) & ($ millions)
Table 80. Global Cell-Free DNA Blood Collection Tubes Sales Forecast by Application (2027-2032) & (Tubes)
Table 81. Global Cell-Free DNA Blood Collection Tubes Revenue Forecast by Application (2027-2032) & ($ millions)
Table 82. Becton, Dickinson and Company Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 83. Becton, Dickinson and Company Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 84. Becton, Dickinson and Company Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 85. Becton, Dickinson and Company Main Business
Table 86. Becton, Dickinson and Company Latest Developments
Table 87. Greiner Bio-One GmbH Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 88. Greiner Bio-One GmbH Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 89. Greiner Bio-One GmbH Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 90. Greiner Bio-One GmbH Main Business
Table 91. Greiner Bio-One GmbH Latest Developments
Table 92. Streck, LLC Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 93. Streck, LLC Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 94. Streck, LLC Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 95. Streck, LLC Main Business
Table 96. Streck, LLC Latest Developments
Table 97. SARSTEDT AG & Co. KG Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 98. SARSTEDT AG & Co. KG Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 99. SARSTEDT AG & Co. KG Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 100. SARSTEDT AG & Co. KG Main Business
Table 101. SARSTEDT AG & Co. KG Latest Developments
Table 102. SEKISUI MEDICAL CO., LTD. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 103. SEKISUI MEDICAL CO., LTD. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 104. SEKISUI MEDICAL CO., LTD. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 105. SEKISUI MEDICAL CO., LTD. Main Business
Table 106. SEKISUI MEDICAL CO., LTD. Latest Developments
Table 107. Liuyang Sanli Medical Technology Development Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 108. Liuyang Sanli Medical Technology Development Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 109. Liuyang Sanli Medical Technology Development Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 110. Liuyang Sanli Medical Technology Development Co., Ltd. Main Business
Table 111. Liuyang Sanli Medical Technology Development Co., Ltd. Latest Developments
Table 112. Hebei Xinle Sci&Tech Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 113. Hebei Xinle Sci&Tech Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 114. Hebei Xinle Sci&Tech Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 115. Hebei Xinle Sci&Tech Co., Ltd. Main Business
Table 116. Hebei Xinle Sci&Tech Co., Ltd. Latest Developments
Table 117. Improve Medical Instruments Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 118. Improve Medical Instruments Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 119. Improve Medical Instruments Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 120. Improve Medical Instruments Co., Ltd. Main Business
Table 121. Improve Medical Instruments Co., Ltd. Latest Developments
Table 122. Norgen Biotek Corp. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 123. Norgen Biotek Corp. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 124. Norgen Biotek Corp. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 125. Norgen Biotek Corp. Main Business
Table 126. Norgen Biotek Corp. Latest Developments
Table 127. Nonacus Limited Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 128. Nonacus Limited Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 129. Nonacus Limited Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 130. Nonacus Limited Main Business
Table 131. Nonacus Limited Latest Developments
Table 132. SOYAGREENTEC CO., LTD. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 133. SOYAGREENTEC CO., LTD. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 134. SOYAGREENTEC CO., LTD. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 135. SOYAGREENTEC CO., LTD. Main Business
Table 136. SOYAGREENTEC CO., LTD. Latest Developments
Table 137. LABEX INC. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 138. LABEX INC. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 139. LABEX INC. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 140. LABEX INC. Main Business
Table 141. LABEX INC. Latest Developments
Table 142. AccuGene, Inc. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 143. AccuGene, Inc. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 144. AccuGene, Inc. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 145. AccuGene, Inc. Main Business
Table 146. AccuGene, Inc. Latest Developments
Table 147. Jiangsu CoWin Biotech Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu CoWin Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 149. Jiangsu CoWin Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 150. Jiangsu CoWin Biotech Co., Ltd. Main Business
Table 151. Jiangsu CoWin Biotech Co., Ltd. Latest Developments
Table 152. Hefei Lakebio Medical Technologies Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 153. Hefei Lakebio Medical Technologies Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 154. Hefei Lakebio Medical Technologies Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 155. Hefei Lakebio Medical Technologies Co., Ltd. Main Business
Table 156. Hefei Lakebio Medical Technologies Co., Ltd. Latest Developments
Table 157. Shandong Ande Healthcare Apparatus Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 158. Shandong Ande Healthcare Apparatus Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 159. Shandong Ande Healthcare Apparatus Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 160. Shandong Ande Healthcare Apparatus Co., Ltd. Main Business
Table 161. Shandong Ande Healthcare Apparatus Co., Ltd. Latest Developments
Table 162. BGI Biotechnology Wuhan Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 163. BGI Biotechnology Wuhan Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 164. BGI Biotechnology Wuhan Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 165. BGI Biotechnology Wuhan Co., Ltd. Main Business
Table 166. BGI Biotechnology Wuhan Co., Ltd. Latest Developments
Table 167. Changsha Renji Medical Equipment Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 168. Changsha Renji Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 169. Changsha Renji Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 170. Changsha Renji Medical Equipment Co., Ltd. Main Business
Table 171. Changsha Renji Medical Equipment Co., Ltd. Latest Developments
Table 172. Zhejiang SKG Medical Technology Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 173. Zhejiang SKG Medical Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 174. Zhejiang SKG Medical Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 175. Zhejiang SKG Medical Technology Co., Ltd. Main Business
Table 176. Zhejiang SKG Medical Technology Co., Ltd. Latest Developments
Table 177. Huachenyang Shenzhen Technology Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 178. Huachenyang Shenzhen Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 179. Huachenyang Shenzhen Technology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 180. Huachenyang Shenzhen Technology Co., Ltd. Main Business
Table 181. Huachenyang Shenzhen Technology Co., Ltd. Latest Developments
Table 182. Dewei Medical Equipment Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 183. Dewei Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 184. Dewei Medical Equipment Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 185. Dewei Medical Equipment Co., Ltd. Main Business
Table 186. Dewei Medical Equipment Co., Ltd. Latest Developments
Table 187. Guangdong Ardent Biomed Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 188. Guangdong Ardent Biomed Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 189. Guangdong Ardent Biomed Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 190. Guangdong Ardent Biomed Co., Ltd. Main Business
Table 191. Guangdong Ardent Biomed Co., Ltd. Latest Developments
Table 192. Nasmed Diagnostics Pvt. Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 193. Nasmed Diagnostics Pvt. Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 194. Nasmed Diagnostics Pvt. Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 195. Nasmed Diagnostics Pvt. Ltd. Main Business
Table 196. Nasmed Diagnostics Pvt. Ltd. Latest Developments
Table 197. Aixgen Technology Heze Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 198. Aixgen Technology Heze Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 199. Aixgen Technology Heze Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 200. Aixgen Technology Heze Co., Ltd. Main Business
Table 201. Aixgen Technology Heze Co., Ltd. Latest Developments
Table 202. YALI Biotech Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 203. YALI Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 204. YALI Biotech Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 205. YALI Biotech Co., Ltd. Main Business
Table 206. YALI Biotech Co., Ltd. Latest Developments
Table 207. Xiamen Zhixuan Biotechnology Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 208. Xiamen Zhixuan Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 209. Xiamen Zhixuan Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 210. Xiamen Zhixuan Biotechnology Co., Ltd. Main Business
Table 211. Xiamen Zhixuan Biotechnology Co., Ltd. Latest Developments
Table 212. BioDetect Xiamen Biotechnology Co., Ltd. Basic Information, Cell-Free DNA Blood Collection Tubes Manufacturing Base, Sales Area and Its Competitors
Table 213. BioDetect Xiamen Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Product Portfolios and Specifications
Table 214. BioDetect Xiamen Biotechnology Co., Ltd. Cell-Free DNA Blood Collection Tubes Sales (Tubes), Revenue ($ Million), Price (US$/Tube) and Gross Margin (2021-2026)
Table 215. BioDetect Xiamen Biotechnology Co., Ltd. Main Business
Table 216. BioDetect Xiamen Biotechnology Co., Ltd. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Cell-Free DNA Blood Collection Tubes
Figure 2. Cell-Free DNA Blood Collection Tubes Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cell-Free DNA Blood Collection Tubes Sales Growth Rate 2021-2032 (Tubes)
Figure 7. Global Cell-Free DNA Blood Collection Tubes Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Cell-Free DNA Blood Collection Tubes Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Cell-Free DNA Blood Collection Tubes Sales Market Share by Country/Region (2025)
Figure 10. Cell-Free DNA Blood Collection Tubes Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Dedicated cfDNA Preservation Tubes
Figure 12. Product Picture of Multi-Analyte Cell-Free Nucleic Acid Preservation Tubes
Figure 13. Product Picture of Other
Figure 14. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Type in 2026
Figure 15. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Up to 5 mL
Figure 17. Product Picture of More than 5 mL and Less than 10 mL
Figure 18. Product Picture of 10 mL and Above
Figure 19. Product Picture of Other
Figure 20. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Blood Draw Volume in 2026
Figure 21. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Blood Draw Volume (2021-2026)
Figure 22. Cell-Free DNA Blood Collection Tubes Consumed in Non-Invasive Prenatal Testing
Figure 23. Global Cell-Free DNA Blood Collection Tubes Market: Non-Invasive Prenatal Testing (2021-2026) & (Tubes)
Figure 24. Cell-Free DNA Blood Collection Tubes Consumed in Cancer Screening and Early Detection
Figure 25. Global Cell-Free DNA Blood Collection Tubes Market: Cancer Screening and Early Detection (2021-2026) & (Tubes)
Figure 26. Cell-Free DNA Blood Collection Tubes Consumed in Therapy Selection and Companion Diagnostics
Figure 27. Global Cell-Free DNA Blood Collection Tubes Market: Therapy Selection and Companion Diagnostics (2021-2026) & (Tubes)
Figure 28. Cell-Free DNA Blood Collection Tubes Consumed in Molecular Residual Disease Monitoring
Figure 29. Global Cell-Free DNA Blood Collection Tubes Market: Molecular Residual Disease Monitoring (2021-2026) & (Tubes)
Figure 30. Cell-Free DNA Blood Collection Tubes Consumed in Transplant Rejection Monitoring
Figure 31. Global Cell-Free DNA Blood Collection Tubes Market: Transplant Rejection Monitoring (2021-2026) & (Tubes)
Figure 32. Cell-Free DNA Blood Collection Tubes Consumed in Other
Figure 33. Global Cell-Free DNA Blood Collection Tubes Market: Other (2021-2026) & (Tubes)
Figure 34. Global Cell-Free DNA Blood Collection Tubes Sale Market Share by Application (2025)
Figure 35. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Application in 2025
Figure 36. Cell-Free DNA Blood Collection Tubes Sales by Company in 2025 (Tubes)
Figure 37. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Company in 2025
Figure 38. Cell-Free DNA Blood Collection Tubes Revenue by Company in 2025 ($ millions)
Figure 39. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Company in 2025
Figure 40. Global Cell-Free DNA Blood Collection Tubes Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share by Geographic Region in 2025
Figure 42. Americas Cell-Free DNA Blood Collection Tubes Sales 2021-2026 (Tubes)
Figure 43. Americas Cell-Free DNA Blood Collection Tubes Revenue 2021-2026 ($ millions)
Figure 44. APAC Cell-Free DNA Blood Collection Tubes Sales 2021-2026 (Tubes)
Figure 45. APAC Cell-Free DNA Blood Collection Tubes Revenue 2021-2026 ($ millions)
Figure 46. Europe Cell-Free DNA Blood Collection Tubes Sales 2021-2026 (Tubes)
Figure 47. Europe Cell-Free DNA Blood Collection Tubes Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales 2021-2026 (Tubes)
Figure 49. Middle East & Africa Cell-Free DNA Blood Collection Tubes Revenue 2021-2026 ($ millions)
Figure 50. Americas Cell-Free DNA Blood Collection Tubes Sales Market Share by Country in 2025
Figure 51. Americas Cell-Free DNA Blood Collection Tubes Revenue Market Share by Country (2021-2026)
Figure 52. Americas Cell-Free DNA Blood Collection Tubes Sales Market Share by Type (2021-2026)
Figure 53. Americas Cell-Free DNA Blood Collection Tubes Sales Market Share by Application (2021-2026)
Figure 54. United States Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Cell-Free DNA Blood Collection Tubes Sales Market Share by Region in 2025
Figure 59. APAC Cell-Free DNA Blood Collection Tubes Revenue Market Share by Region (2021-2026)
Figure 60. APAC Cell-Free DNA Blood Collection Tubes Sales Market Share by Type (2021-2026)
Figure 61. APAC Cell-Free DNA Blood Collection Tubes Sales Market Share by Application (2021-2026)
Figure 62. China Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 66. India Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Cell-Free DNA Blood Collection Tubes Sales Market Share by Country in 2025
Figure 70. Europe Cell-Free DNA Blood Collection Tubes Revenue Market Share by Country (2021-2026)
Figure 71. Europe Cell-Free DNA Blood Collection Tubes Sales Market Share by Type (2021-2026)
Figure 72. Europe Cell-Free DNA Blood Collection Tubes Sales Market Share by Application (2021-2026)
Figure 73. Germany Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 74. France Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Cell-Free DNA Blood Collection Tubes Sales Market Share by Application (2021-2026)
Figure 81. Egypt Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Cell-Free DNA Blood Collection Tubes Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Cell-Free DNA Blood Collection Tubes in 2026
Figure 87. Manufacturing Process Analysis of Cell-Free DNA Blood Collection Tubes
Figure 88. Industry Chain Structure of Cell-Free DNA Blood Collection Tubes
Figure 89. Channels of Distribution
Figure 90. Global Cell-Free DNA Blood Collection Tubes Sales Market Forecast by Region (2027-2032)
Figure 91. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Cell-Free DNA Blood Collection Tubes Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Cell-Free DNA Blood Collection Tubes Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Cell-Free DNA Blood Collection Tubes Revenue Market Share Forecast by Application (2027-2032)